Xadago

MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 20, 2023
Approval ID: c4d65f28-983f-42b4-bb23-023ae0fe81b2
Products: 2 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XADAGO safely and effectively. See full prescribing information for XADAGO . XADAGO (safinamide) tablets, for oral use. Initial U.S. Approval: 2017

Quick Stats

Total Products2

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.